Lexeo Therapeutics, Inc. (LXEO)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Nov. 25, 2025 | CORRESP | Neutral/Informational | Moderate | Lexeo Therapeutics, Inc. has submitted a correspondence to the SEC requesting the acceleration of their Registration Statement on Form S-3, which is set to be effective on Novembe… | Read Filing EDGAR |
| Jun. 27, 2025 | CORRESP | Neutral/Informational | Moderate | Lexeo Therapeutics, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by June 30, 202… | Read Filing EDGAR |
| Jun. 26, 2025 | CORRESP | Neutral/Informational | Moderate | Lexeo Therapeutics, Inc. submitted a response to the SEC regarding comments on their Registration Statement on Form S-3, filed on June 13, 2025. The SEC raised a question about th… | Read Filing EDGAR |
| Jun. 18, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has conducted a limited review of Lexeo Therapeutics, Inc.'s registration statement on Form S-3 filed on June 13, 2025, and has issued a comment regarding the registration… | Read Filing EDGAR |